Search results
I work with impassioned scientists at Novartis, a global medicines company, where I lead portfolio strategy, partnering, and access-to-medicine solutions for the Global Health research...
View full-text. Jonathan Spector's 37 research works with 816 citations and 8,766 reads, including: Coherence in measurement and programming in maternal and newborn health: Experience from...
7 de abr. de 2022 · “There are clear signs that climate change will have a substantial impact on health,” says Jonathan Spector, Head of Global Health Strategy and Access to Innovation at the Novartis Institutes for BioMedical Research.
23 de jun. de 2022 · Thierry Diagana and Jonathan Spector from the Novartis Institute for Tropical Diseases (NITD) discuss learnings about their work in Neglected Tropical Diseases (NTDs) and share insights into the factors, which could lead to a resurgence of these diseases. By Christine Elleboode-Zwaans | Jun 23, 2022. Novartis endorses the Kigali ...
Head, Global Health Strategy & Partnering @ Novartis Biomedical Research | Pharmaceuticals, Public Health, Humanitarian Medicine 1d
25 de abr. de 2018 · Jonathan M. Spector https://orcid.org/0000-0002-4738-8933 Novartis Institutes for BioMedical Research, Cambridge, MA 02139, USA. View all articles by this author
18 de mar. de 2021 · PMCID: PMC7972183. DOI: 10.1186/s40795-021-00410-w. Abstract. Background: Sickle cell disease (SCD) is an inherited blood disorder that predominantly affects individuals in sub-Saharan Africa. However, research that elucidates links between SCD pathophysiology and nutritional status in African patients is lacking.
